Eleanor P. Taranto, MD
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 3rd Floor West
Make an appointmentCall 215-615-5858
Penn Medicine Provider

About me

  • Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Dr. Taranto is a medical oncologist specializing in breast cancer. She provides compassionate care tailored to each patient's unique journey. She takes a collaborative approach, guiding patients through treatment with empathy and clarity. Dr. Taranto helps to connect patients to innovative clinical trials, offering access to emerging therapies while advancing cancer research. She considers it a privilege to support patients during their course of treatment at Penn Medicine.

Education and training

  • Medical School: University of Chicago
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Taranto is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

E. P. Taranto, W. Fawn, C. Desirae, E. Walinsky, S. Deluca, L. Bayne, E. P. Wileyto, A. Shirali, C. J. Robbins, Y. Abdou, J. Anampa, M. Balic, J. V. Canzoniero, N. C. Chen, F. Howard, L. Huppert, A. Kahn, C. Mainor, J. Mouabbi, V. Nair, T.Degeer, J. Weidler, T. McNicholas, C. Serway, J. Reischl, M. Bates, R. Monroe, D. L. Rimm, A. DeMichele Quantifyher (trial in progress): quantitative immunofluorescence and/or messenger rna to measure her2 expression in patients with metastatic breast cancer treated with trastuzumab deruxtecan (tbcrc066) , San Antonio Breast Cancer Symposium : 2025

A. DeMichele, L. Bayne, E. Walinsky, L. Berry, S. Deluca, C. G. Smith, A. Chevalier, B. Ambasager, P. Sanchez, J. Heaven, E. Chislock, , T. Pan, J. Graves, G. Belka, J. Wang, E. Taranto, A. Nayak, M. Feldman, A. Clark, L. Chodosh 5-year outcomes and ctdna findings in the clever trial targeting disseminated dormant tumor cells , San Antonio Breast Cancer Symposium : 2025

Taranto E, Seewald NJ, Bayne LJ, Deluca S, Shih NC, Sanchez P, Nivar I, Ambasager B, Murray C, Chevalier A, Smith CG, Makhlin I, Rohn K, Goodspeed BL, Savage J, Wileyto P, Wang J, Belka G, Chislock E, Berry LR, Berry D, Nayak A, Feldman M, Clark AS, Chodosh LA, & DeMichele A. Circulating tumor DNA (ctDNA), dormant disseminated tumor cells (DTCs) and recurrence outcomes in breast cancer survivors on the SURMOUNT Study. , San Antonio Breast Cancer Symposium, San Antonio, TX.: 2024

Taranto E, Hwang WT, Alfaro M, Surapaneni AS, Gill SK, Feldman T, Randall MP, Spinner MA, Furqan F, Shah NN, Samara Y, Mei MG, Herrera AF, Moskowitz A, Shah GL, & Svoboda J. Engraftment Syndrome during Autologous Stem Cell Transplant in Hodgkin Lymphoma Patients Treated with Checkpoint Inhibitors: A Multicenter Retrospective analysis. , ASH Annual Meeting, San Diego, CA.: 2023

Taranto E, Barta S, Bhansali R. Central Nervous System Relapse in T and NK Cell Lymphomas , Curr Hematol Malig Rep, 18(6): 2023,243-251.

Merryman R, Redd R, Taranto E, Ahmed G, Jeter E, McHugh K, Brown J, Crombie J, Davids M, Fisher D, Freedman A, Jacobsen E, Jacobson C, Kim A, LaCasce A, Lampson B, Ng S, Odejide O, Dahi P, Nieto Y, Joyce R, Chen Y, Herrera A, Armand P. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. , Blood Adv, 7(17): 2023,4748-4759.

Merryman R, Spilberg G, Mondello P, Redd R, Taranto E, Ahmed G, Jeter E, Chase M, Salles G, Zelenetz A, Brown J, Crombie J, Davids M, Fisher D, Freedman A, Jacobsen E, Jacobson C, Kim A, LaCasce A, Lampson B, Ng S, Odejide O, Armand P, Jacene H. Interim Positron Emission Tomography during Frontline Chemoimmunotherapy for Follicular Lymphoma , Hemasphere , 7(2): 2023,e826.

Taranto E, Redd R, Jeter E, McHugh K, Crombie JL, Fisher DC, Jacobsen E, Jacobson CA, Kim AI, Odejide OO, Dahi PB, Nieto Y, Joyce RM, Chen YB, Bonjoc KC, Chaudhry A, Herrera AF, Armand P, Merryman RW. Prognostic Value of Minimal Residual Disease among Patients with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation , Leuk Lymphoma, 63(12): 2022,2912-2917.

Kline J, Heusinkveld L, Taranto E, Martin C, Tomasi A, Hsu I, Cho K, Khillan J, Murphy P & Pontejo S. Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue. , J Biol Chem , 296: 2021,100373.

Taranto E, Fishman M, Garvey K, Perlman M, Benjamin H, & Ross LF. Public Attitudes and Knowledge About Youth Sports Participation and Concussion Risk in an Urban Area. , J Natl Med Assoc, 110(6): 2018,635-643.